Clopidogrel resistance and genetic factors
Copyright policy )Clopidogrel resistance and genetic factors
Dual antiplatelet therapy combining aspirin and clopidogrel is the standart care for patients WHO ave ACS or undergoing PCI according to guidelines.Itss well established that the antiplatelet response to clopidogrel varies widely among patients.Patients displaying little attenuation of platelet reactivity under therapy are recognized as clopidogrel resistant.Different mechanisms responsible for the phenomenon of clopidogrel resistance have been suggested with genetic polymorphisms being one of the most widely studied.
Male, clopidogrel, Polymorphism, Genetic, R, Integrin beta3, Coronary Artery Disease, RC31-1245, genetic polimorphism, RC666-701, Medicine, Diseases of the circulatory (Cardiovascular) system, Humans, Antigens, Human Platelet, Female, Internal medicine, coronary artery disease
Male, clopidogrel, Polymorphism, Genetic, R, Integrin beta3, Coronary Artery Disease, RC31-1245, genetic polimorphism, RC666-701, Medicine, Diseases of the circulatory (Cardiovascular) system, Humans, Antigens, Human Platelet, Female, Internal medicine, coronary artery disease
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!